Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Its reported effects on modulating inflammatory pathways make it a candidate for managing arthritis, joint pain, and other inflammatory disorders
It is essential to note that tirzepatide has no FDA-approved indication for treating substance use disorders
Phase 3 trials currently underway Seven TRIUMPH trials are testing retatrutide across multiple indications: TRIUMPH-1 : Obesity without diabetes TRIUMPH-2 : Type 2 diabetes TRIUMPH-3 : Obesity with type 2 diabetes TRIUMPH-4 : Obesity with knee osteoarthritis (COMPLETED, 28.7% weight loss) TRIUMPH-5 : Obstructive sleep apnea TRIUMPH-6 and 7 : Additional indications These trials will provide the definitive data for the commercial dosage chart
Muoio DM, Noland RC, Kovalik JP, Seiler SE, Davies MN, DeBalsi KL, Ilkayeva OR, Stevens RD, Kheterpal I, Zhang J, Covington JD, Bajpeyi S, Ravussin E, Kraus W, Koves TR, Mynatt RL (2012) Muscle-specific deletion of Carnitine Acetyltransferase Compromises glucose tolerance and metabolic flexibility
For extended storage (beyond 6 months), refrigerate at 2-8C
US$ 22.86
US$ 22.77
US$ 27.02
US$ 21.33
